BACKGROUND AND AIMS: SPARC (secreted protein acidic, rich in cysteine) is a matricellular protein that has been found to be activated in a number of human cancers. More recently, it has been shown to be upregulated in human gastric and colorectal cancer. We therefore wished to address the functional importance of SPARC upregulation to intestinal tumorigenesis in vivo. METHODS: SPARC upregulation was determined in intestinal adenomas of tumour-prone Apc(Min/+) mice at both the RNA and the protein level. To determine the functional importance of SPARC for intestinal tumorigenesis we then intercrossed Sparc knockout mice with Apc(Min/+) mice (n = 20). Intestinal enterocyte migration was examined using bromodeoxyuridine labelling studies. RESULTS: Levels of murine Sparc and several related proteins were upregulated in adenomas arising in Apc(Min/+) mice. A deficiency of Sparc strongly suppressed adenoma formation in Apc(Min/+) mice (p>or=0.0001). Importantly, a deficiency of Sparc also accelerated enterocyte migration (p = 0.01), as perturbed slow epithelial migration may underpin adenoma formation in the intestine. CONCLUSIONS: These data implicate Sparc in both cell migration and tumour formation, and identify Sparc as a potential therapeutic target for colorectal cancer.
BACKGROUND AND AIMS: SPARC (secreted protein acidic, rich in cysteine) is a matricellular protein that has been found to be activated in a number of human cancers. More recently, it has been shown to be upregulated in human gastric and colorectal cancer. We therefore wished to address the functional importance of SPARC upregulation to intestinal tumorigenesis in vivo. METHODS: SPARC upregulation was determined in intestinal adenomas of tumour-prone Apc(Min/+) mice at both the RNA and the protein level. To determine the functional importance of SPARC for intestinal tumorigenesis we then intercrossed Sparc knockout mice with Apc(Min/+) mice (n = 20). Intestinal enterocyte migration was examined using bromodeoxyuridine labelling studies. RESULTS: Levels of murine Sparc and several related proteins were upregulated in adenomas arising in Apc(Min/+) mice. A deficiency of Sparc strongly suppressed adenoma formation in Apc(Min/+) mice (p>or=0.0001). Importantly, a deficiency of Sparc also accelerated enterocyte migration (p = 0.01), as perturbed slow epithelial migration may underpin adenoma formation in the intestine. CONCLUSIONS: These data implicate Sparc in both cell migration and tumour formation, and identify Sparc as a potential therapeutic target for colorectal cancer.
Authors: I Takemasa; H Higuchi; H Yamamoto; M Sekimoto; N Tomita; S Nakamori; R Matoba; M Monden; K Matsubara Journal: Biochem Biophys Res Commun Date: 2001-08-03 Impact factor: 3.575
Authors: Rolf A Brekken; Pauli Puolakkainen; David C Graves; Gail Workman; Sharon R Lubkin; E Helene Sage Journal: J Clin Invest Date: 2003-02 Impact factor: 14.808
Authors: J Brabender; R V Lord; R Metzger; J Park; D Salonga; K D Danenberg; P V Danenberg; A H Hölscher; P M Schneider Journal: Br J Cancer Date: 2003-10-20 Impact factor: 7.640
Authors: Heather L Mentrup; Amanda Hartman; Elizabeth L Thames; Wassim A Basheer; Lydia E Matesic Journal: Differentiation Date: 2017-12-15 Impact factor: 3.880
Authors: Daniel Drev; Felix Harpain; Andrea Beer; Anton Stift; Elisabeth S Gruber; Martin Klimpfinger; Sabine Thalhammer; Andrea Reti; Lukas Kenner; Michael Bergmann; Brigitte Marian Journal: Cancers (Basel) Date: 2019-09-24 Impact factor: 6.639
Authors: Charles E Patek; Mark J Arends; Lorraine Rose; Feijun Luo; Marion Walker; Paul S Devenney; Rachel L Berry; Nicola J Lawrence; Rachel A Ridgway; Owen J Sansom; Martin L Hooper Journal: BMC Gastroenterol Date: 2008-06-13 Impact factor: 3.067